Library›Substances and pharmacology›Cannabinoid Oilahuasca

Cannabinoid Oilahuasca

Cannabinoid Oilahuasca is the Van Kush Family Research Institute's framework for extending the classical ayahuasca pharmacology to the endocannabinoid system. The structural argument is a single analogy carried through:

Classical ayahuasca combines DMT — orally inactive on its own — with MAO inhibitors from Banisteriopsis caapi that prevent its breakdown. The combination is the medicine; neither half is.

Cannabinoid Oilahuasca applies the same logic to the body's own cannabinoids: combine cannabinoids with MAGL and FAAH inhibitors to potentiate endocannabinoid signalling rather than simply adding more agonist. The term oilahuasca comes from the wider practice of using fats and oils to alter oral bioavailability of plant actives.

The two enzymes

• MAGL (monoacylglycerol lipase) degrades 2-AG, and accounts for ~85% of its hydrolysis in the brain. Inhibiting it raises 2-AG and lowers arachidonic acid, the inflammatory precursor.
• FAAH (fatty acid amide hydrolase) degrades anandamide. Inhibiting it raises anandamide, with anxiolytic and analgesic effect.

The natural inhibitors

MAGL:

• 8-Prenylnaringenin — hops. IC50 = 9.5 μM, the most potent natural MAGL inhibitor identified. Also a potent phytoestrogen; promotes neurogenesis.
• Pristimerin — Celastraceae. Reversible, terpenoid, less selective.
• Euphol — Euphorbia. Reversible, triterpene, anti-inflammatory.

FAAH:

• Yangonin — kava. Kavalactone with CB1 affinity; anxiolytic.
• Guineensine — black pepper. FAAH and reuptake inhibitor.
• Macamides — maca. N-benzylamides; neuroprotective.
• Biochanin A — red clover, soy. Also oestrogenic.

Downstream:

• β-Caryophyllene — dietary CB2 agonist, GRAS, non-psychoactive, present in black pepper, cloves, cannabis, Imphepho and Artemisia capillaris.

The Piperaceae convergence

The pepper family supplies four different kinds of activity to this system: yangonin (kava) inhibits FAAH and binds CB1; guineensine (black pepper) inhibits FAAH and reuptake; piperine (black pepper) inhibits CYP3A4, CYP2D6 and P-glycoprotein to raise bioavailability; β-caryophyllene agonises CB2. That one family covers enzyme, transport, absorption and receptor is the strongest single argument for treating this as a framework rather than a list.

Bioavailability Dynamics: First-Pass Avoidance and Grapefruit Inhibition

A core limitation in oral cannabinoid and allylbenzene therapy is extensive hepatic Phase I oxidation and Phase II glucuronidation. Two complementary pharmacological strategies overcome this barrier:

• Grapefruit Juice and Furanocoumarin Suicide Inhibition: Grapefruit (*Citrus paradisi*) contains furanocoumarins—principally 6',7'-dihydroxybergamottin (6',7'-DHB) and bergamottin. These act as mechanism-based, irreversible ("suicide") inactivators of intestinal Cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp / ABCB1). By permanently disabling enterocyte CYP3A4 until new enzymes are biosynthesized (24–72 hours), co-administering grapefruit juice dramatically boosts systemic AUC for orally ingested cannabinoids and terpenes (see Bioavailability: Metabolic Enzymes, Transporters, and Synergistic Delivery).
• Transmucosal and Sublingual Driving: Bypassing the gastrointestinal tract and portal vein entirely via sublingual absorption routes lipophilic cannabinoids directly into the internal jugular vein and systemic circulation. When paired with natural biosurfactants like triterpenoid saponins from African Ubulawu (*Helinus integrifolius*, *Silene undulata*), mucosal tight junctions are loosened and salivary amylase/mucin barriers are bypassed, achieving rapid, injection-like bioavailability without first-pass hepatic loss.

Lineage: from Space Paste to Oilahuasca

Pharmacologically and historically, Cannabinoid Oilahuasca adapts principles first explored in Alexander Shulgin's structural analysis of plant allylbenzenes, the underground "Space Paste" protocols, and the forum work of 69Ron:

• Space Paste: Combined whole nutmeg, black pepper, cinnamon, and herbs in a crude poly-herbal mixture, relying on unstandardized allylbenzenes (myristicin, elemicin, safrole) alongside natural inhibitors.
• 69Ron and the Oilahuasca Formulation: Documented on DMT-Nexus and Herbpedia, 69Ron pioneered sequential enzyme inhibition paired with micro-doses of essential oils. His Herbpedia writings openly confirm that he had never consumed MDMA, mescaline, or LSD, explaining why psychonauts seeking heavy recreational trips were disappointed while those seeking subtle neuromodulation observed real shifts (see 69Ron and Oilahuasca Chemistry).
• The Oswald Pathway and Mace: Biomedical research by E.O. Oswald established that allylbenzenes form tertiary amino-alkaloid metabolites in vivo via vinyl ketone intermediates and secondary amines (piperidine, dimethylamine). Furthermore, utilizing mace rather than whole nutmeg seed dramatically reduces heavy trimyristin fat ballast (see Allylbenzene Metabolism, Oswald Pathway, and Mace).
• Traditional Poly-Herbal Blends: For the biochemical rationale behind the classic "Coffee, Almond, Cinnamon, Vanilla, and Nutmeg" mixture alongside historical Bedouin spiced coffee, Roman/Medieval spiced wine (Hippocras), and Betel Nut (Paan) preparations, see Traditional Spiced Formulations and Synergistic Blends.
• Metabolic and Structural Dynamics: For the precise enzymology of 2-AG biosynthesis, spontaneous 1,2-acyl migration, and clearance, see Endocannabinoid Chemistry and 2-AG Metabolism. For terpene membrane fluidization and antioxidant protection, see Antioxidants and Cannabinoid Stability.

ECRI

ECRI — endocannabinoid reuptake inhibitor — is the operator's 2016 coinage for the class, named by analogy with the SSRIs: do not supply the ligand, prolong the one already present. It is a framing term originating in this corpus and is not established pharmacological nomenclature; it is used here because it names the strategy accurately.

Status of the claims

The enzymology is real and published: MAGL and FAAH do what is described, and the named compounds do inhibit them in vitro. What is not established is that consuming the plants delivers those compounds at inhibitory concentrations in a human being, or that doing so produces the intended clinical effect. The gap between an in vitro IC50 and a dietary exposure is usually orders of magnitude, and this framework should be read as a research programme rather than a finding.

The clearest known hazard is on the other side: chronic complete MAGL inhibition causes CB1 desensitisation and tolerance in animal models. More inhibition is not better, and the reversible natural inhibitors may be preferable for exactly that reason.

See also: MAGL · FAAH · Anandamide and 2-AG · Endocannabinoid Chemistry and 2-AG Metabolism · Shulgin Ten Essential Amphetamines and Metabolic Chemistry · Antioxidants and Cannabinoid Stability · Beta-Caryophyllene · 8-Prenylnaringenin · Kava · Black Pepper · Maca · Stack Substances · Cannabis

Filed under  Substances and pharmacology